An overview of chronic oral graft-vs-host disease following pediatric hematopoietic stem cell transplantation - PubMed (original) (raw)
Review
. 2008 Mar-Apr;30(2):98-104.
Affiliations
- PMID: 18481573
Review
An overview of chronic oral graft-vs-host disease following pediatric hematopoietic stem cell transplantation
Marcio A da Fonseca et al. Pediatr Dent. 2008 Mar-Apr.
Abstract
Hematopoietic stem cell transplant (HSCT) is the treatment of choice for many hematologic, genetic, oncologic, and immunologic diseases. It is also one of the most aggressive treatments among the different cancer therapies, however, and is associated with severe conditioning-related toxicity, profound neutropenia, a high level of prophylactic immunosuppression and graft-vs-host disease (GVHD). Even with GVHD prophylaxis, chronic GVHD remains a significant complication of HSCT and is a frequent reason for nonrelapse morbidity and mortality following allogeneic HSCT. It primarily targets the skin, gastrointestinal tract, and liver. Approximately 20% of patients who receive matched sibling transplants and 40% of matched unrelated donor recipients will develop chronic GVHD. Risk factors include: (1) history of acute GVHD; (2) hemotologic malignancy; (3) female donor to male recipient; (4) use of total body irradiation; (5) donor age of > or = 5 years; and (6) recipients >10 years of age. The purpose of this paper was to review the pathogenesis, prevention, and treatment of pediatric chronic graft-vs-host disease, with a focus on its oral manifestations and the dental management of affected children and adolescents.
Similar articles
- Safety of hematopoietic stem cell transplantation in children less than three years of age.
Dvorak CC, Wright NB, Wong WB, Kristovich KM, Matthews EW, Weinberg KI, Amylon MD, Agarwal R. Dvorak CC, et al. Pediatr Hematol Oncol. 2008 Dec;25(8):705-22. doi: 10.1080/08880010802243524. Pediatr Hematol Oncol. 2008. PMID: 19065437 - Skin explant model of human graft-versus-host disease: prediction of clinical outcome and correlation with biological risk factors.
Wang XN, Collin M, Sviland L, Marshall S, Jackson G, Schulz U, Holler E, Karrer S, Greinix H, Elahi F, Hromadnikova I, Dickinson AM. Wang XN, et al. Biol Blood Marrow Transplant. 2006 Feb;12(2):152-9. doi: 10.1016/j.bbmt.2005.09.018. Biol Blood Marrow Transplant. 2006. PMID: 16443513 Clinical Trial. - Graft-versus-host disease: a complex long-term side effect of hematopoietic stem cell transplant.
Barton-Burke M, Dwinell DM, Kafkas L, Lavalley C, Sands H, Proctor C, Johnson E. Barton-Burke M, et al. Oncology (Williston Park). 2008 Oct;22(11 Suppl Nurse Ed):31-45. Oncology (Williston Park). 2008. PMID: 19856578 Review. - Graft-versus-host disease: review and nursing implications.
Mattson MR. Mattson MR. Clin J Oncol Nurs. 2007 Jun;11(3):325-8. doi: 10.1188/07.CJON.325-328. Clin J Oncol Nurs. 2007. PMID: 17623617 Review. - Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
Creamer D, Martyn-Simmons CL, Osborne G, Kenyon M, Salisbury JR, Devereux S, Pagliuca A, Ho AY, Mufti GJ, du Vivier AW. Creamer D, et al. Arch Dermatol. 2007 Sep;143(9):1157-62. doi: 10.1001/archderm.143.9.1157. Arch Dermatol. 2007. PMID: 17875877
Cited by
- Carcinoma of the lip five years after bone marrow transplantation.
Ardore M, Berrone M, Marchitto G, Gandolfo S, Pentenero M. Ardore M, et al. Ann Stomatol (Roma). 2015 Dec 1;6(Suppl 1 to n 2):38. eCollection 2015 Apr-Jun. Ann Stomatol (Roma). 2015. PMID: 27051476 Free PMC article. No abstract available. - Graft-versus-host disease affecting oral cavity. A review.
Margaix-Muñoz M, Bagán JV, Jiménez Y, Sarrión MG, Poveda-Roda R. Margaix-Muñoz M, et al. J Clin Exp Dent. 2015 Feb 1;7(1):e138-45. doi: 10.4317/jced.51975. eCollection 2015 Feb. J Clin Exp Dent. 2015. PMID: 25810826 Free PMC article. Review. - Oral manifestations in the Graft versus Host Disease in paediatric patients: case report.
Maturo P, Condò R, Costacurta M, Docimo R. Maturo P, et al. Oral Implantol (Rome). 2009 Apr;2(2):34-41. Epub 2010 Mar 4. Oral Implantol (Rome). 2009. PMID: 23285361 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical